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I have read with interest the recent paper by Liu 
and Zhang [1] on the putative association of the 
PRSS1 gene with pancreatitis. In their article, the au-
thors claim a highly significant association based on a 
meta-analysis of seven previous case-control studies. 
Their methodological approach, however, warrants a 
cautionary comment. 
To assess the impact of PRSS1 mutations, the 
authors have conceptualized the entire gene as a 
risk-modifier. Thus instead of counting carriers of a 
single variant, all carriers of at least one variant were 
supposedly grouped together. Clearly, a metaanalysis 
in this fashion is quite uninformative. A gene is made 
up of numerous DNA base pairs of which some may 
augment the risk for disease, while others may act in 
the opposite direction and yet others act neutrally 
with regard to a given phenotype. Similar 
risk-enhancing effects of genetic variants within the 
same gene imply that linkage disequilibrium between 
these markers is very high. This does not apply to 
PRSS1 mutations and therefore no rationale exists for 
indiscriminate pooling of mutations or polymor-
phisms (i.e. N29I, N29T, L104P, R116C, A121T, 
R122H, R122C, T137M, C139S, D162D, G208A) across 
the gene. 
When data are re-analyzed for the two most 
commonly examined mutations (N29I and R122H) 
assuming a dominant mode of inheritance for the 
minor allele under a random effects model, and ap-
plying a Bonferroni correction, the overall net effect 
remains significant for R122H (pcorrected = .03) but is 
only borderline significant for N29I (pcorrected = .05, Fig. 
1). When the same analysis is restricted to European 
populations, significance is lost for N29I (pcorrected > .09). 
Moreover, the true effect of PRSS1 variants is likely 
obscured by pooling of all age-groups, pooling of 
acute and chronic phenotypes, pooling of early and 
late onset phenotypes, plus pooling of primary and 
secondary forms of pancreatitis. Future analyses will 
need to reassess in more detail the association with 
PRSS1 for subjects with respect to high and low ge-
netic load. 
 
 
 
Fig. 1. Forest plots for 
metaanalyses of all studies 
addressing PRSS1 carrier 
status for N29I (top) and 
R122H (bottom). 
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